Bone Biologics Corp (BBLG)
1.19
-0.10
(-7.75%)
USD |
NASDAQ |
Nov 15, 16:00
1.24
+0.05
(+4.20%)
After-Hours: 20:00
Bone Biologics Enterprise Value: -0.1884M for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | -0.1884M |
| November 14, 2024 | -0.0083M |
| November 13, 2024 | -0.2064M |
| November 12, 2024 | -0.1704M |
| November 11, 2024 | 0.0458M |
| November 08, 2024 | 0.1178M |
| November 07, 2024 | 0.0098M |
| November 06, 2024 | 0.0098M |
| November 05, 2024 | 0.1719M |
| November 04, 2024 | -0.0083M |
| November 01, 2024 | 0.0098M |
| October 31, 2024 | 0.0998M |
| October 30, 2024 | 0.0998M |
| October 29, 2024 | 0.1719M |
| October 28, 2024 | 0.7844M |
| October 25, 2024 | 0.7844M |
| October 24, 2024 | 0.7663M |
| October 23, 2024 | 0.7483M |
| October 22, 2024 | 0.9285M |
| October 21, 2024 | 1.235M |
| October 18, 2024 | 1.307M |
| October 17, 2024 | 0.9285M |
| October 16, 2024 | 1.055M |
| October 15, 2024 | 0.334M |
| October 14, 2024 | 0.5322M |
| Date | Value |
|---|---|
| October 11, 2024 | 0.6763M |
| October 10, 2024 | 0.6943M |
| October 09, 2024 | 0.7663M |
| October 08, 2024 | 0.8744M |
| October 07, 2024 | 1.037M |
| October 04, 2024 | 0.7663M |
| October 03, 2024 | 0.8564M |
| October 02, 2024 | 0.4061M |
| October 01, 2024 | 1.415M |
| September 30, 2024 | 1.505M |
| September 27, 2024 | 1.901M |
| September 26, 2024 | 2.226M |
| September 25, 2024 | 1.847M |
| September 24, 2024 | 1.577M |
| September 23, 2024 | 1.163M |
| September 20, 2024 | 1.541M |
| September 19, 2024 | 0.9465M |
| September 18, 2024 | 1.415M |
| September 17, 2024 | 0.7844M |
| September 16, 2024 | 1.073M |
| September 13, 2024 | -0.8909M |
| September 12, 2024 | -0.1884M |
| September 11, 2024 | -0.2785M |
| September 10, 2024 | -0.3444M |
| September 09, 2024 | -0.2785M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-5.211M
Minimum
Jun 15 2023
69.19M
Maximum
Nov 01 2021
6.036M
Average
-0.7758M
Median
Mar 11 2024
Enterprise Value Benchmarks
| Johnson & Johnson | 386.23B |
| Dermata Therapeutics Inc | -3.473M |
| NovaBay Pharmaceuticals Inc | 2.764M |
| Palatin Technologies Inc | 8.735M |
| iBio Inc | 6.468M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.7837M |
| Total Expenses (Quarterly) | 0.8097M |
| EPS Diluted (Quarterly) | -0.67 |
| Earnings Yield | -820.3% |